Gesynta Pharma
SwedenEntry
2025
Hold
1yr
Status
Active
Who owns Gesynta Pharma?
Gesynta Pharma is currently owned by XGen Venture SGR through XGEN Venture Life Sciences Fund (2022 vintage), since 2025. Across its history, Gesynta Pharma has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-23
Most recent investor
XGen Venture SGRXGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2019 · present
IndustrifondenActive
2019 · present(7yr) · Industrifonden Evergreen · 1991 · VC
XGen Venture SGRActive
2025 · present(1yr) · XGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
HealthCapActive
2025 · present(1yr) · HealthCap VIII · 2021 · VC
More from XGEN Venture Life Sciences Fund
Other portfolio companies in the same fund.
Italy
UK
Switzerland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Gesynta Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Gesynta Pharma?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Gesynta Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue